Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J Paddon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Reviews. Microbiology|April 2, 2014
Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical developmentChris J Paddon, Jay D Keasling
Current Opinion in Biotechnology|January 2, 2016
Developing fermentative terpenoid production for commercial usageMichael D Leavell, Derek J McPhee, Chris J Paddon
Frontiers in Plant Science|February 16, 2018
Approaches and Recent Developments for the Commercial Production of Semi-synthetic ArtemisininStephanie H Kung, Sean Lund, Abhishek Murarka, et al.
Metabolic Engineering|January 24, 2007
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coliDouglas J Pitera, Chris J Paddon, Jack D Newman, et al.
BMC Biotechnology|November 6, 2008
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acidDae-Kyun Ro, Mario Ouellet, Eric M Paradise, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2012
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisininPatrick J Westfall, Douglas J Pitera, Jacob R Lenihan, et al.
Microbial Cell Factories|March 28, 2012
De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnologyJurgen F Nijkamp, Marcel van den Broek, Erwin Datema, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Reviews. Microbiology|April 2, 2014
Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical developmentChris J Paddon, Jay D Keasling
Current Opinion in Biotechnology|January 2, 2016
Developing fermentative terpenoid production for commercial usageMichael D Leavell, Derek J McPhee, Chris J Paddon
Frontiers in Plant Science|February 16, 2018
Approaches and Recent Developments for the Commercial Production of Semi-synthetic ArtemisininStephanie H Kung, Sean Lund, Abhishek Murarka, et al.
Metabolic Engineering|January 24, 2007
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coliDouglas J Pitera, Chris J Paddon, Jack D Newman, et al.
BMC Biotechnology|November 6, 2008
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acidDae-Kyun Ro, Mario Ouellet, Eric M Paradise, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2012
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisininPatrick J Westfall, Douglas J Pitera, Jacob R Lenihan, et al.
Microbial Cell Factories|March 28, 2012
De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnologyJurgen F Nijkamp, Marcel van den Broek, Erwin Datema, et al.
Pageof 1